You have 9 free searches left this month | to do more

ly2157299

Ly2157299 is a drug used to treat Glioma, Hepatocellular Carcinoma, Healthy Volunteers, and other conditions. Ly2157299 is being actively studied in 3 studies and prior, has been studied in 7.

Top SponsorsTop SitesTop Investigators
Eli Lilly and CompanyFor additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Providence Health & ServicesNorthwestern University
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsFor additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559 ) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Recruiting
  • Rectal Adenocarcinoma
  • LY2157299
  • +3 more
  • Portland, Oregon
    Providence Cancer Center
2020-09-14
Sep 14, 2020
S
Recruiting
  • Prostate Cancer
  • Washington, District of Columbia
  • +3 more
2021-09-29
Sep 29, 2021
E
Active, not recruiting
  • Glioma
  • Baltimore, Maryland
  • +3 more
2021-08-17
Aug 17, 2021
E
Completed
  • Hepatocellular Carcinoma
  • Chiba, Japan
  • +2 more
2020-02-03
Feb 3, 2020
E
Completed
  • Hepatocellular Carcinoma
  • LY2157299
  • +2 more
  • Beijing, China
  • +15 more
2021-04-30
Apr 30, 2021
E
Completed
  • Carcinoma, Hepatocellular
  • LY2157299
  • +2 more
  • Fayetteville, Arkansas
  • +39 more
2020-12-21
Dec 21, 2020
E
Completed
  • Neoplasms
  • Neoplasm Metastasis
  • LY2157299
  • Tokyo, Japan
    For additional information regarding investigative sites for thi
2014-06-30
Jun 30, 2014
E
Completed
  • Healthy Volunteers
  • LY2157299
  • Daytona Beach, Florida
    For additional information regarding investigative sites for thi
2013-12-03
Dec 3, 2013